Cook Medical to Explore Issues Affecting the Periphery at the 10th Annual Vascular InterVentional Advances (VIVA) Meeting

Cook’s breadth of presentations highlights company’s commitment to the evolving field of peripheral intervention

LAS VEGAS--(BUSINESS WIRE)--Cook Medical will host multiple sessions on issues affecting the periphery at the 10^th annual Vascular InterVentional Advances (VIVA) meeting in Las Vegas. Led by world-renowned physicians, Cook’s presentations will examine the current state of the stenting market, a global look at peripheral arterial disease (PAD) and new approaches in limb preservation.

WHEN	October 9 -12, 2012
WHERE	Cook Medical Pavilion Booth #101, Premiere Suite #4 Wynn Las Vegas 3131 Las Vegas Blvd. South Las Vegas, NV 89109
WHAT	A glance at Cook’s scheduled sessions:
	How Often Will We Use Drug-Eluting Stents – What Patients/Lesions Will Be the Most Likely to Benefit? Featuring: Michael Dake, M.D., Stanford Hospital Tuesday, October 9, 2012 at 8:19 a.m. PDT; General Session
	Why Drug Eluting Technologies Will Be the Standard of Care in the SFA Featuring: Michael Dake, M.D., Stanford Hospital; Mark Burket, M.D., University of Toledo Medical Center, Toledo, Ohio; and Andrew Holden, M.D., Auckland City Hospital, New Zealand Tuesday, October 9, 2012 at 12:00 p.m. PDT; Cook Pavilion
	Breakfast Symposium and Interactive Master Class: Tibiopedal Access and Amputation Prevention Featuring: Craig Walker, M.D., Terrebone General Hospital, Houma, LA; George Adams, M.D., Rex Health, North Carolina; Jihad Mustapha, M.D., Metro Heart & Vascular Institute; and Marco Manzi, M.D., Abano Terme, Italy Wednesday, October 10, 2012 at 7:00 a.m. PDT; Cook Pavilion
	Update on 3-Year Zilver PTX Randomized Data Featuring: Michael Dake, M.D., Stanford Hospital Wednesday, October 10, 2012 at 1:20 p.m. PDT; General Session
	Is There Clinical Benefit to Using Drug-Eluting Technologies Over POBA and Bare Metal Stents? Featuring: Dierk Scheinert, M.D., Leipzig. Germany Thursday, October 11, 2012 at 8:26 a.m. PDT; General Session
	How Will Drug Eluting Technologies Impact Your Practice Clinically and Economically? Featuring: Gary Ansel, M.D., Riverside Methodist Hospital; Mark Burket, M.D., University of Toledo Medical Center, Toledo, Ohio; and Dierk Scheinert, M.D., Leipzig. Germany Thursday, October 11, 2012 at 12:00 p.m. PDT; Cook Pavilion

About Vascular InterVentional Advances (VIVA)

Vascular InterVentional Advances, VIVA, is celebrating 10 years of defining excellence in professional education in the field of vascular intervention and medicine.

Over the past decade, VIVA has attracted a multispecialty audience and provided a broad and well-rounded educational experience for all participants involved in the care of patients with vascular disease. Attendees include those from vascular surgery, interventional cardiology, vascular medicine, interventional radiology, neuroradiology, neurosurgery, and cardiothoracic surgery.

About Cook Medical

A global pioneer in medical breakthroughs, Cook Medical is committed to creating effective solutions that benefit millions of patients worldwide. Today, we combine medical devices, drugs, biologic grafts and cell therapies across more than 16,000 products serving more than 40 medical specialties. Founded in 1963 by a visionary who put patient needs and ethical business practices first, Cook is a family-owned company that has created more than 10,000 jobs worldwide. For more information, visit www.cookmedical.com. Follow Cook Medical on Twitter and LinkedIn.